{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T16:04:48Z","timestamp":1785168288247,"version":"3.55.0"},"reference-count":38,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2018,6,6]],"date-time":"2018-06-06T00:00:00Z","timestamp":1528243200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","award":["GS\u2010US\u2010174\u20100208"],"award-info":[{"award-number":["GS\u2010US\u2010174\u20100208"]}],"id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Journal of Viral Hepatitis"],"published-print":{"date-parts":[[2018,11]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Entecavir 0.5\u00a0mg (<jats:styled-content style=\"fixed-case\">ETV<\/jats:styled-content>) is widely used among treatment\u2010na\u00efve chronic hepatitis B (<jats:styled-content style=\"fixed-case\">CHB<\/jats:styled-content>) patients. However, 10%\u201030% of patients show partial virologic response (<jats:styled-content style=\"fixed-case\">PVR<\/jats:styled-content>) to the drug. If the hepatitis B virus (<jats:styled-content style=\"fixed-case\">HBV<\/jats:styled-content>) continues to replicate, the underlying liver disease may progress. Herein, we compared the efficacy of switching to tenofovir disoproxil fumarate (<jats:styled-content style=\"fixed-case\">TDF<\/jats:styled-content>) with that of continuing <jats:styled-content style=\"fixed-case\">ETV<\/jats:styled-content> in <jats:styled-content style=\"fixed-case\">CHB<\/jats:styled-content> patients with <jats:styled-content style=\"fixed-case\">PVR<\/jats:styled-content> to <jats:styled-content style=\"fixed-case\">ETV<\/jats:styled-content>. This was an open\u2010label randomized controlled trial including <jats:styled-content style=\"fixed-case\">CHB<\/jats:styled-content> patients who had been receiving 0.5\u00a0mg of <jats:styled-content style=\"fixed-case\">ETV<\/jats:styled-content> for &gt;12\u00a0months, but who still had detectable <jats:styled-content style=\"fixed-case\">HBV DNA<\/jats:styled-content> levels of &gt;60\u00a0<jats:styled-content style=\"fixed-case\">IU<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">mL<\/jats:styled-content> without known resistance to <jats:styled-content style=\"fixed-case\">ETV<\/jats:styled-content>. Sixty patients were enrolled and 45 qualified for the study: Twenty\u2010two patients were randomly assigned into the <jats:styled-content style=\"fixed-case\">TDF<\/jats:styled-content> group and 23 into the <jats:styled-content style=\"fixed-case\">ETV<\/jats:styled-content> group. After 12\u00a0months of treatment, the virologic response rate (<jats:styled-content style=\"fixed-case\">HBV DNA<\/jats:styled-content> &lt;20\u00a0<jats:styled-content style=\"fixed-case\">IU<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">mL<\/jats:styled-content>) was significantly higher in the <jats:styled-content style=\"fixed-case\">TDF<\/jats:styled-content> group than in the <jats:styled-content style=\"fixed-case\">ETV<\/jats:styled-content> group, as measured using per\u2010protocol analysis (55% vs 20%; <jats:italic>P\u00a0<\/jats:italic>=<jats:italic>\u00a0<\/jats:italic>.022) and intention\u2010to\u2010treat analysis (50% vs 17.4%; <jats:italic>P\u00a0<\/jats:italic>=<jats:italic>\u00a0<\/jats:italic>.020). The reduction in <jats:styled-content style=\"fixed-case\">HBV DNA<\/jats:styled-content> was greater (\u22121.13 vs \u22120.67 log<jats:sub>10<\/jats:sub> <jats:styled-content style=\"fixed-case\">IU<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">mL<\/jats:styled-content>;<jats:italic> P\u00a0<\/jats:italic>=<jats:italic>\u00a0<\/jats:italic>.024), and the mean <jats:styled-content style=\"fixed-case\">HBV DNA<\/jats:styled-content> level was lower (1.54 vs 2.01 log<jats:sub>10<\/jats:sub> <jats:styled-content style=\"fixed-case\">IU<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">mL<\/jats:styled-content>;<jats:italic> P\u00a0<\/jats:italic>=<jats:italic>\u00a0<\/jats:italic>.011) in the <jats:styled-content style=\"fixed-case\">TDF<\/jats:styled-content> group than in the <jats:styled-content style=\"fixed-case\">ETV<\/jats:styled-content> group. In conclusion, to achieve optimal response in <jats:styled-content style=\"fixed-case\">CHB<\/jats:styled-content> patients with <jats:styled-content style=\"fixed-case\">PVR<\/jats:styled-content> to <jats:styled-content style=\"fixed-case\">ETV<\/jats:styled-content>, switching to <jats:styled-content style=\"fixed-case\">TDF<\/jats:styled-content> would be a better strategy than continuing <jats:styled-content style=\"fixed-case\">ETV<\/jats:styled-content>. Appropriate modification of therapy would further improve the outcome of chronic <jats:styled-content style=\"fixed-case\">HBV<\/jats:styled-content> infection.<\/jats:p>","DOI":"10.1111\/jvh.12934","type":"journal-article","created":{"date-parts":[[2018,5,17]],"date-time":"2018-05-17T18:59:41Z","timestamp":1526583581000},"page":"1321-1330","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Switching to tenofovir vs continuing entecavir for hepatitis B virus with partial virologic response to entecavir: a randomized controlled trial"],"prefix":"10.1111","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6036-2754","authenticated-orcid":false,"given":"H. J.","family":"Yim","sequence":"first","affiliation":[{"name":"Department of Internal Medicine Korea University Ansan Hospital  Ansan South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I. H.","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine Chonbuk National University Hospital  Jeonju South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. J.","family":"Suh","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine Korea University Ansan Hospital  Ansan South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y. K.","family":"Jung","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine Korea University Ansan Hospital  Ansan South Korea"},{"name":"Department of Internal Medicine Gachon University Gil Hospital  Incheon South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. H.","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine Korea University Guro Hospital  Seoul South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y. S.","family":"Seo","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine Korea University Anam Hospital  Seoul South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. E.","family":"Yeon","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine Korea University Guro Hospital  Seoul South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. W.","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine Uijeongbu St. Mary\u2019s Hospital, The Catholic University of Korea  Seoul Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Y.","family":"Kwon","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine Konkuk University Hospital  Seoul South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. H.","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine Hallym University Kangnam Sacred Heart Hospital  Seoul South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. S.","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine Hallym University Kangnam Sacred Heart Hospital  Seoul South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. H.","family":"Um","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine Korea University Anam Hospital  Seoul South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. S.","family":"Byun","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine Korea University Guro Hospital  Seoul South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,6,6]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20956"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28156"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.03.021"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2016.22.1.18"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2015.21.1.1"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051285"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051287"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2015.21.1.24"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.3109\/00365521.2012.719927"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24406"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27889"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2012-302024"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28916"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0802878"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2011.01533.x"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-012-2402-2"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1159\/000360399"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26180"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/liv.13253"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2013.02.002"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2014.09.009"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.5009\/gnl.2013.7.6.712"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2005.20.5.816"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1159\/000081740"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2010.10.011"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-014-3486-7"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2009.12.020"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2012.12.013"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22841"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-008-9108-8"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.295.1.65"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.11.016"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2012.02.007"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2009.01168.x"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2014.20.3.223"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2013.12.028"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2014-308353"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2014-308435"}],"container-title":["Journal of Viral Hepatitis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjvh.12934","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jvh.12934","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T17:12:48Z","timestamp":1694884368000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jvh.12934"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,6]]},"references-count":38,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["10.1111\/jvh.12934"],"URL":"https:\/\/doi.org\/10.1111\/jvh.12934","archive":["Portico"],"relation":{},"ISSN":["1352-0504","1365-2893"],"issn-type":[{"value":"1352-0504","type":"print"},{"value":"1365-2893","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,6]]},"assertion":[{"value":"2017-07-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-04-16","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-06-06","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}